NASDAQ · Biotechnology

Notable Labs, Ltd. (NTBL) Stock

$0.25 -27.68% NASDAQ: NTBL Healthcare

Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer.

Valuation

MetricValue
Price$0.25
Market Cap$2.39M
P/E Ratio-0.05
P/B Ratio0.04
P/S Ratio7.72
EPS (TTM)$-5.03
52-Week High$4.24
52-Week Low$0.22
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-59.97%
ROA-57.64%
ROCE-87.23%
Gross Margin36.45%
Operating Margin—
Net Margin—
Debt/Equity0.14
Current Ratio5.65

Annual Financials (USD)

Metric20192020202120222023
Revenue$1.0M$1.0M$0$0$0
Operating Profit$-20.0M$-24.0M$-17.0M$-13.0M$-15.0M
Net Profit$-19.0M$-24.0M$-16.0M$-14.0M$-11.0M
EPS$-0.38$-0.48$-0.22$-6.50$-5.03
Op Margin-3573.3%-2655.4%-5934.7%-161550.0%-4728.1%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$49.0M$42.0M$8.0M$30.0M$20.0M
Total Liabilities$13.0M$11.0M$62.0M$7.0M$4.0M
Cash$9.0M$13.0M$2.0M$18.0M$12.0M
Borrowings$3.0M$3.0M$2.0M$1.0M$2.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-13.0M$-23.0M$-15.0M$-12.0M$-14.0M
Investing Cash Flow$-6.0M$10.0M$14.0M$1.0M$15.0M
Financing Cash Flow$0$0$0$4.0M$4.0M
Net Cash Flow$-20.0M$4.0M$1.0M$-1.0M$10.0M
Free Cash Flow$-13.0M$-23.0M$-15.0M$-12.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.51
FCF Yield-575.51%
Quick Ratio4.60
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARAVAravive, Inc. $0.04 -13.39% -0.02 $2.95M 0.00%
ATNXAthenex, Inc. $0.20 +0.00% -0.01 $2.33M 0.00%
BPTSBiophytis S.A. $8.22 -13.47% -0.57 $2.61M 0.00%
EIGRQEiger BioPharmaceuticals, Inc. $8.50 +6.25% -0.17 $12.59M 0.00%
FRESFresh2 Group Limited $0.85 -23.42% 0.00 $2.08M 0.00%

About Notable Labs, Ltd.

Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.

Notable Labs, Ltd. is headquartered in IL.

Notable Labs, Ltd. (NTBL) stock trades at $0.25 with a market capitalization of $2.39M. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 0.04, price-to-sales of 7.72. Over the past 52 weeks the stock has ranged between $0.22 and $4.24, and currently trades 94.1% below its 52-week high.

On profitability, Notable Labs, Ltd. generates a return on equity (ROE) of -59.97%, return on capital employed of -87.23%.

Official website: www.notablelabs.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides